ESC 365 - European ABSORB Consortium: Outcome of 10312 patients after Everolimus-bioresorbable scaffold implantation

ESC Premium Access

European ABSORB Consortium: Outcome of 10312 patients after Everolimus-bioresorbable scaffold implantation

Session: Late Breaking Science in Interventional Cardiology 2

Topic: Revascularisation

Speaker: Professor H. Nef (Giessen, DE)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Holger Nef

Justus-Liebig University of Giessen, Giessen (Germany)

7 presentations

0 follower

12 more presentations in this session

Panel discussants.

Report from SCAAR - Pretreatment with P2Y12 Receptor Antagonists is not Associated with Improved Clinical Outcomes in UA/NSTEMI

Speaker: Professor E. Omerovic (Gothenburg, SE)

Panel discussion.

FAME 2 - PCI reduces 5-year death or myocardial infarction in patients with silent ischemia and stable coronary artery disease

Speaker: Doctor S. Fournier (Lausanne, CH)

Panel discussion.

Access the full session

Late Breaking Science in Interventional Cardiology 2

Speakers: Professor H. Nef, Professor E. Omerovic, Doctor S. Fournier

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by